jiangsu weiqida pharmaceutical co., ltd
Trade trend analysis
Mon
|
Year
Number of Transactions Quantity Weight
Number of Transactions Quantity Weight
The above chart presents the market trend analysis for jiangsu weiqida pharmaceutical co., ltd from 2025 to 2026. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2026, the company has completed 10 transactions, with a transaction quantity of 11460 and a transaction weight of 0.
- Year Transactions Quantity Weight
- 2025 28 21201.15 2973.52
- 2026 10 11460 0
Bill of lading data
< 1/15 >- Trade date 2026/06/05 B/L No. 108311206510
- Suppliers jiangsu weiqida pharmaceutical co., ltd Buyers công ty cổ phần dược hậu giang
- POLs —— PODs ——
- Supply area Other Purchas area Vietnam
- Weight —— Amount 542000
- Hs code 29419000 Product tags ceftriaxone sodium,entercavir,neomycin sulphate
- Product description AZITHROMYCIN DIHYDRATE USP-NF2025. Nguyên liệu dược để sx thuốc, kháng sinh, dạng bột. Số lô: AZK-2603051 đến AZK-2603054 NSX: 03/2026- Retest: 03/2030 Expand
- Trade date 2026/06/02 B/L No. 108299382000
- Suppliers jiangsu weiqida pharmaceutical co., ltd Buyers công ty tnhh biorich pharma
- POLs —— PODs ——
- Supply area Other Purchas area Vietnam
- Weight —— Amount 10950
- Hs code 29415000 Product tags erythromycin,erythromycin ethyl succinate,erythromycin stearate
- Product description Nguyên liệu dược Azithromycin (Azithromycin dihydrate). Số đăng kí lưu hành: 893110813624 (SĐK cũ: VD-26997-17); Tiêu chuẩn: USP 2024; Số lô: AZK-2512026; NXS: 25/12/2025; HSD: 24/12/2029; mới 100% Expand
- Trade date 2026/05/11 B/L No. 108227202901
- Suppliers jiangsu weiqida pharmaceutical co., ltd Buyers công ty tnhh biorich pharma
- POLs —— PODs ——
- Supply area Other Purchas area Vietnam
- Weight —— Amount 10950
- Hs code 29415000 Product tags erythromycin,erythromycin ethyl succinate,erythromycin stearate
- Product description Nguyên liệu dược Azithromycin (Azithromycin dihydrate). Số đăng kí lưu hành: 893110813624 (SĐK cũ: VD-26997-17); Tiêu chuẩn: USP-NF2024; Số lô: AZK-2507016; NXS: 13/07/2025; HSD: 12/07/2029; Mới 100% Expand
- Trade date 2026/04/20 B/L No. 108165296960
- Suppliers jiangsu weiqida pharmaceutical co., ltd Buyers công ty cổ phần dược phẩm opv
- POLs —— PODs ——
- Supply area Other Purchas area Vietnam
- Weight —— Amount 21000
- Hs code 29415000 Product tags erythromycin,erythromycin ethyl succinate,erythromycin stearate
- Product description Dược chất Azithromycin Dihydrate, TC UPS2025, NLSX Thuốc, Batch: AZK-2603018 (Mfg: 12/03/2026,Retest: 11/03/2030). Mới 100%(DM7, Mục 93, 09/2024/TT-BYT) Expand
- Trade date 2026/04/20 B/L No. 108165158360
- Suppliers jiangsu weiqida pharmaceutical co., ltd Buyers công ty cổ phần dược phẩm opv
- POLs —— PODs ——
- Supply area Other Purchas area Vietnam
- Weight —— Amount 28000
- Hs code 29415000 Product tags erythromycin,erythromycin ethyl succinate,erythromycin stearate
- Product description Dược chất Azithromycin Dihydrate, TC UPS2025, NLSX Thuốc, Batch: AZK-2603017, (Mfg: 12/03/2026,Retest: 11/03/2030),NSX: JIANGSU WEIQIDA PHARMACEUTICAL CO.,LTD. Mới 100%(DM7, Mục 93, 09/2024/TT-BYT) Expand
- Trade date 2026/04/20 B/L No. 108165296960
- Suppliers jiangsu weiqida pharmaceutical co., ltd Buyers công ty cổ phần dược phẩm opv
- POLs —— PODs ——
- Supply area Other Purchas area Vietnam
- Weight —— Amount 35000
- Hs code 29415000 Product tags erythromycin,erythromycin ethyl succinate,erythromycin stearate
- Product description Dược chất Azithromycin Dihydrate, TC UPS2025, NLSX Thuốc, Batch: AZK-2603017 (Mfg: 12/03/2026,Retest: 11/03/2030). Mới 100%(DM7, Mục 93, 09/2024/TT-BYT) Expand
- Trade date 2026/04/03 B/L No. 108114634460
- Suppliers jiangsu weiqida pharmaceutical co., ltd Buyers công ty cp dược vật tư y tế hà nam
- POLs —— PODs ——
- Supply area Other Purchas area Vietnam
- Weight —— Amount 42840
- Hs code 29231000 Product tags choline
- Product description Choline alfoscerate , tiêu chuẩn: In house, nguyên liệu sx thuốc, batch GPB-2509008, ngày sx:18.09.2025, hạn sd:17.09.2028, 30kg/drum, nhà sx: JIANGSU WEIQIDA PHARMACEUTICAL CO., LTD. mới 100% Expand
- Trade date 2026/03/30 B/L No. 108098208260
- Suppliers jiangsu weiqida pharmaceutical co., ltd Buyers công ty cổ phần dược hậu giang
- POLs —— PODs ——
- Supply area Other Purchas area Vietnam
- Weight —— Amount 413250
- Hs code 29419000 Product tags ceftriaxone sodium,entercavir,neomycin sulphate
- Product description AZITHROMYCIN DIHYDRATE USP-NF2025. Nguyên liệu dược để sx thuốc, kháng sinh, dạng bột. Số lô: AZK-2602004 đến AZK-2602007 NSX: 02/2026- Retest: 02/2030 Expand
- Trade date 2026/03/16 B/L No. 108055491240
- Suppliers jiangsu weiqida pharmaceutical co., ltd Buyers công ty cổ phần dược phẩm opv
- POLs —— PODs ——
- Supply area Other Purchas area Vietnam
- Weight —— Amount 28000
- Hs code 29415000 Product tags erythromycin,erythromycin ethyl succinate,erythromycin stearate
- Product description Dược chất Azithromycin Dihydrate, tiêuchuẩn UPS2025, NLSX Thuốc, Batch: AZK-2507016, (Mfg: 13/07/2025, Exp: 12/07/2029), Nhà SX:JIANGSU WEIQIDA PHARMACEUTICAL CO.,LTD.Mới 100%(DM7,Mục 93, 09/2024/BYT) Expand
- Trade date 2026/02/27 B/L No. 108006454400
- Suppliers jiangsu weiqida pharmaceutical co., ltd Buyers công ty cổ phần dược hậu giang
- POLs —— PODs ——
- Supply area Other Purchas area Vietnam
- Weight —— Amount 413250
- Hs code 29419000 Product tags ceftriaxone sodium,entercavir,neomycin sulphate
- Product description AZITHROMYCIN DIHYDRATE USP-NF2025.Nguyên liệu dược để sx thuốc, kháng sinh, dạng bột. Số lô: AZK-2510002+ AZK-2512017+ AZK-2512027+ AZK-2512028 NSX: 12/2025- Retest: 12/2029. Expand
- Trade date 2025/12/06 B/L No. 107777299230
- Suppliers jiangsu weiqida pharmaceutical co., ltd Buyers công ty cổ phần dược phẩm tv pharm
- POLs —— PODs ——
- Supply area Other Purchas area Vietnam
- Weight —— Amount 728
- Hs code 29415000 Product tags erythromycin,erythromycin ethyl succinate,erythromycin stearate
- Product description Dược chất là NLSX Thuốc: Azithromycin dihydrate (USP 2025). NSX: Jiangsu Weiqida Pharmaceutical. Lot: AZA-2505007 (Date 05/2025_05/2029). Expand
- Trade date 2025/11/24 B/L No. 107733006360
- Suppliers jiangsu weiqida pharmaceutical co., ltd Buyers công ty tnhh liên doanh stellapharm chi nhánh 1
- POLs —— PODs ——
- Supply area Other Purchas area Vietnam
- Weight —— Amount 206700
- Hs code 29415000 Product tags erythromycin,erythromycin ethyl succinate,erythromycin stearate
- Product description Nguyên liệu sx thuốc: Azithromycin Dihydrate USP-NF2025. Lô:AZK-2507055, AZK-2507056. Năm sx: 08/2025. Hạn dùng: 07/2029. TT09 DM7 mục 93 Expand
- Trade date 2025/11/13 B/L No. 107702741313
- Suppliers jiangsu weiqida pharmaceutical co., ltd Buyers công ty cổ phần dược hậu giang
- POLs —— PODs ——
- Supply area Other Purchas area Vietnam
- Weight —— Amount 550000
- Hs code 29419000 Product tags ceftriaxone sodium,entercavir,neomycin sulphate
- Product description AZITHROMYCIN DIHYDRATE USP-NF2025.Nguyên liệu dược để sx thuốc, kháng sinh, dạng bột. Số lô:từ AZK-2507032 đến AZK-2507035. NSX: 07/2025- Retest: 07/2029. NSX: JIANGSU WEIQIDA PHARMACEUTICAL CO., LTD. Expand
- Trade date 2025/10/30 B/L No. 107660552640
- Suppliers jiangsu weiqida pharmaceutical co., ltd Buyers công ty cổ phần dược phẩm trung ương i pharbaco
- POLs —— PODs ——
- Supply area China Purchas area Vietnam
- Weight —— Amount 3339.9
- Hs code 29231000 Product tags choline
- Product description Choline Alfoscerate; In house; Nguyên liệu sản xuất thuốc; Mới 100%; Batchno: GPB-2509009; Ngày sx: 20/09/2025; Hạn sd: 19/09/2025; Nhà sx: Jiangsu Weiqida Pharmaceutical Co.,Ltd Expand
- Trade date 2025/10/30 B/L No. 107660761610
- Suppliers jiangsu weiqida pharmaceutical co., ltd Buyers công ty cổ phần dược phẩm trung ương i pharbaco
- POLs —— PODs ——
- Supply area China Purchas area Vietnam
- Weight —— Amount 31884.3
- Hs code 29231000 Product tags choline
- Product description Choline Alfoscerate; In house; Nguyên liệu sản xuất thuốc; Mới 100%; Batchno: GPB-2509009; Ngày sx: 20/09/2025; Hạn sd: 19/09/2027; Nhà sx: Jiangsu Weiqida Pharmaceutical Co.,Ltd Expand
Partners
Total 49- Rank Company Transactions Per Detail
- 1 công ty cổ phần dược hậu giang vietnambuyer,they trade on 2026-06-05 10 10.99% >
- 2 bbcon api ltd. bangladeshbuyer,they trade on 2025-10-06 5 5.49% >
- 3 công ty cổ phần dược phẩm opv vietnambuyer,they trade on 2026-04-20 4 4.40% >
- 4 bosch pharmaceutical pvt ltd. pakistanbuyer,they trade on 2022-03-10 3 3.30% >
- 5 focus rulz pharmaceutical pvt ltd. pakistanbuyer,they trade on 2025-10-29 3 3.30% > +View All
Products
Total 18- Products Transactions Per Detail
-
azithromycin dihydrate
7 41.18% > -
ceftriaxone sodium
4 23.53% > -
entercavir
4 23.53% > -
neomycin sulphate
4 23.53% > -
erythromycin
3 17.65% >
+View All
Hscode rank
Total 15- HSCode Name Transactions Per Detail
- HS 29419011 6 35.29% >
- HS 29419000 4 23.53% >
- HS 29415000 3 17.65% >
- HS 29329900 2 11.76% >
- HS 29419090 1 5.88% > +View All
Trading Area
Total 7- Area Transactions Per Detail
- pakistan 32 35.16% >
- vietnam 29 31.87% >
- bangladesh 23 25.27% >
- brazil 2 2.20% >
- india 2 2.20% > +View All
jiangsu weiqida pharmaceutical co., ltd is china Supplier,
and primarily engages in the import and export business of products such as azithromycin dihydrate，ceftriaxone sodium，entercavir.
According to the 52wmb.com global trade database, as of 2026-06-05, the company has completed 91 international trades,
with its main trading regions covering pakistan，vietnam,bangladesh etc.
The core products include HS29419011，HS29419000，HS29415000 etc,
and its main trading partners are công ty cổ phần dược hậu giang，bbcon api ltd.，công ty cổ phần dược phẩm opv.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on jiangsu weiqida pharmaceutical co., ltd is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.
Reference contact info
Email Hunting Tool